Mercado de Polymarket
Prediction market
Track current outcome prices, market depth, volume, liquidity, and recent trades for Prediction market.
Proximo
- Probabilidad
- 88%
- Liquidez
- $39.22K
- Mejor compra
- 1%
- Mejor venta
- 99%
- Spread
- 98%
- Ultimo trade
- 88%
Outcomes
Resultados del mercado
Precio en vivo
Precio y liquidez
Compra, venta, punto medio, spread y profundidad actuales para este resultado.
- Mejor compra
- 1%
- Mejor venta
- 99%
- Punto medio
- 50%
- Spread
- 98%
- Ultimo trade
- 88%
- Profundidad
- 37.976,46 / 1245,34
Historial de precios
Esperando historial de precios
Historial no disponible
Compras
| Precio | Tamano |
|---|---|
| 1% | 26,105.01 |
| 2% | 1,160 |
| 3% | 11.39 |
| 5% | 10 |
| 8% | 350 |
| 10% | 3,600 |
| 11% | 600 |
| 20% | 1,750 |
Ventas
| Precio | Tamano |
|---|---|
| 99% | 205,01 |
| 98% | 111 |
| 97% | 13,06 |
| 96% | 212,5 |
| 95% | 70 |
| 90% | 51 |
| 88% | 582,77 |
Trades
Trades recientes
Latest visible trades for this market.
- FDA approves Viatris' low-dose estrogen weekly patch?No 12% 20 shares
- FDA approves Viatris' low-dose estrogen weekly patch?No 12% 20 shares
- FDA approves Viatris' low-dose estrogen weekly patch?Yes 87% 20 shares
- FDA approves Viatris' low-dose estrogen weekly patch?No 12% 27 shares
- FDA approves Viatris' low-dose estrogen weekly patch?No 12% 20 shares
- FDA approves Viatris' low-dose estrogen weekly patch?No 12% 20 shares
- FDA approves Viatris' low-dose estrogen weekly patch?No 12% 20 shares
- FDA approves Viatris' low-dose estrogen weekly patch?Yes 88% 28 shares
- FDA approves Viatris' low-dose estrogen weekly patch?Yes 88% 20 shares
- FDA approves Viatris' low-dose estrogen weekly patch?No 12% 41 shares
- FDA approves Viatris' low-dose estrogen weekly patch?Yes 88% 20 shares
- FDA approves Viatris' low-dose estrogen weekly patch?No 17% 20 shares